Acasti Pharma Inc. (ACST)
NASDAQ: ACST · IEX Real-Time Price · USD
2.760
+0.060 (2.22%)
At close: May 16, 2024, 3:16 PM
2.880
+0.120 (4.35%)
After-hours: May 16, 2024, 4:35 PM EDT
Acasti Pharma Market Cap
Acasti Pharma has a market cap or net worth of $25.94 million as of May 16, 2024. Its market cap has increased by 21.22% in one year.
Market Cap
25.94M
Enterprise Value
7.52M
1-Year Change
21.22%
Ranking
Category
Stock Price
$2.76
Market Cap Chart
Since February 14, 2012, Acasti Pharma's market cap has decreased from $3.44B to $25.94M, a decrease of -99.25%. That is a compound annual growth rate of -32.87%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 16, 2024 | 25.90M | 1.97% |
May 15, 2024 | 25.40M | -3.05% |
May 14, 2024 | 26.20M | 1.16% |
May 13, 2024 | 25.90M | - |
May 10, 2024 | 25.90M | - |
May 9, 2024 | 25.90M | -4.78% |
May 8, 2024 | 27.20M | 1.87% |
May 7, 2024 | 26.70M | -3.61% |
May 6, 2024 | 27.70M | -0.36% |
May 3, 2024 | 27.80M | -2.46% |
May 2, 2024 | 28.50M | 6.34% |
May 1, 2024 | 26.80M | 2.68% |
Apr 30, 2024 | 26.10M | 3.57% |
Apr 29, 2024 | 25.20M | -7.69% |
Apr 26, 2024 | 27.30M | -0.73% |
Apr 25, 2024 | 27.50M | 0.73% |
Apr 24, 2024 | 27.30M | 0.74% |
Apr 23, 2024 | 27.10M | 1.12% |
Apr 22, 2024 | 26.80M | -0.74% |
Apr 19, 2024 | 27.00M | -6.57% |
Apr 18, 2024 | 28.90M | -3.67% |
Apr 17, 2024 | 30.00M | -4.76% |
Apr 16, 2024 | 31.50M | -0.32% |
Apr 15, 2024 | 31.60M | -1.25% |
Apr 12, 2024 | 32.00M | - |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Concord Medical Services Holdings | 27.09M |
Oncternal Therapeutics | 26.16M |
Enlivex Therapeutics | 26.02M |
Unity Biotechnology | 25.85M |
CytoMed Therapeutics | 25.85M |
Ekso Bionics Holdings | 25.44M |
NKGen Biotech | 25.22M |
Aptorum Group | 25.18M |